Ackermann Christina

Number of records: 41
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
27-Mar-23 7:54 PM
View: 
Calcimedica, Inc. (CALC) 23-Mar-23Disposition 1,429----100%
0 to 1.43K
03-Mar-23 4:55 PM
View: 
Bausch & Lomb Corp (BLCO) 01-Mar-23Grant 28,344----24%
118.33K to 146.68K
27-Jul-22 7:38 PM
View: 
Bausch & Lomb Corp (BLCO) 25-Jul-22Grant 35,000----42%
83.33K to 118.33K
09-May-22 6:46 PM
View: 
Bausch & Lomb Corp (BLCO) 05-May-22Grant 83,333----100%
0 to 83.33K
11-Mar-22 4:00 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 10-Mar-22Payment of Exercise 839$22.56$18,927.80(< 1%)
163.08K to 162.24K
3%
07-Mar-22 5:45 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 03-Mar-22Payment of Exercise 6,926$23.61$163,523.00(4%)
170.0K to 163.08K
02-Mar-22 9:06 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 27-Feb-22Payment of Exercise 16,028$24.35$390,282.00(9%)
186.03K to 170.0K
02-Mar-22 9:06 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 27-Feb-22Option Exercise 24,292----15%
161.74K to 186.03K
31-Aug-21 4:07 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 27-Aug-21Payment of Exercise 5,017$28.95$145,242.00(3%)
166.76K to 161.74K
04-Jun-21 4:51 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 02-Jun-21Option Exercise 121,198$14.85$1,800,030.0073%
166.76K to 287.96K
04-Jun-21 4:51 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 02-Jun-21Option Sale 121,198$31.83$3,857,730.00(42%)
287.96K to 166.76K
15-Mar-21 4:08 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 11-Mar-21Payment of Exercise 796$32.82$26,124.70(< 1%)
167.55K to 166.76K
10-Mar-21 8:46 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 10-Mar-21Payment of Exercise 21,960$32.97$724,021.00(12%)
189.51K to 167.55K
10-Mar-21 8:46 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 08-Mar-21Grant 25,980----17%
155.08K to 181.06K
10-Mar-21 8:46 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 08-Mar-21Option Exercise 8,455----5%
181.06K to 189.51K
05-Mar-21 5:45 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 03-Mar-21Grant 36,250----31%
118.83K to 155.08K
03-Mar-21 4:26 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 01-Mar-21Payment of Exercise 5,367$31.42$168,631.00(4%)
124.2K to 118.83K
31-Aug-20 6:44 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 28-Aug-20Grant 28,171----29%
96.03K to 124.2K
11-Mar-20 8:52 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 10-Mar-20Grant 4,390----5%
87.25K to 91.64K
11-Mar-20 8:52 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 10-Mar-20Purchase 4,390$18.25$80,105.605%
91.64K to 96.03K
11-Mar-20 8:52 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 09-Mar-20Payment of Exercise 3,343$20.96$70,069.30(4%)
90.59K to 87.25K
(4%)
03-Mar-20 4:52 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 28-Feb-20Payment of Exercise 3,779$24.44$92,358.80(4%)
94.37K to 90.59K
28-Feb-20 7:19 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 26-Feb-20Grant 19,449----26%
74.92K to 94.37K
21-Feb-20 9:52 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 20-Feb-20Payment of Exercise 22,378$26.46$592,122.00(27%)
81.57K to 59.19K
21-Feb-20 9:52 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 19-Feb-20Grant 42,267----90%
47.16K to 89.43K
21-Feb-20 9:52 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 19-Feb-20Option Exercise 7,864----(9%)
89.43K to 81.57K
09-Jan-20 4:17 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 07-Jan-20Payment of Exercise 3,360$29.42$98,851.20(7%)
50.52K to 47.16K
13-Aug-19 4:03 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 12-Aug-19Market Sale (Planned) 3,418$22.45$76,725.60(6%)
53.94K to 50.52K
3%
13-Aug-19 4:03 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 09-Aug-19Payment of Exercise 7,779$22.39$174,172.00(13%)
61.72K to 53.94K
3%
15-Jul-19 4:30 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 11-Jul-19Private Sale (Planned) 3,968$24.81$98,446.10(6%)
65.69K to 61.72K
12-Mar-19 4:17 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 08-Mar-19Payment of Exercise 3,630$23.56$85,522.80(5%)
69.32K to 65.69K
< 1%
01-Mar-19 4:57 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 27-Feb-19Grant 21,310----44%
48.01K to 69.32K
10-Jan-19 4:02 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 08-Jan-19Payment of Exercise 3,446$21.25$73,227.50(7%)
51.46K to 48.01K
(12%)
17-Oct-18 4:15 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 16-Oct-18Market Sale (Planned) 4,542$25.50$115,821.00(8%)
56.0K to 51.46K
7%
17-Oct-18 4:15 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 15-Oct-18Market Sale (Planned) 15,404$24.83$382,481.00(22%)
71.4K to 56.0K
5%
13-Aug-18 5:04 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 09-Aug-18Payment of Exercise 7,779$23.52$182,962.00(10%)
79.18K to 71.4K
(< 1%)
09-Mar-18 8:54 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 07-Mar-18Grant 20,457----35%
58.72K to 79.18K
09-Jan-18 3:25 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 08-Jan-18Payment of Exercise 3,649$23.85$87,028.60(6%)
62.37K to 58.72K
< 1%
11-Aug-17 4:41 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 09-Aug-17Payment of Exercise 6,046$15.37$92,927.00(9%)
68.42K to 62.37K
(54%)
10-Jan-17 7:01 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 06-Jan-17Grant 24,575----56%
43.84K to 68.42K
10-Aug-16 7:33 PM
View: 
Valeant Pharmaceuticals Int... (BHC) 08-Aug-16Grant 122,762----100%
0 to 122.76K